Suppr超能文献

估算消瘦患者的氨基糖苷类药物清除率和肌酐清除率。

Estimating aminoglycoside clearance and creatinine clearance in underweight patients.

机构信息

School of Pharmacy, University of California-San Francisco, CA, USA.

出版信息

Am J Health Syst Pharm. 2010 Feb 15;67(4):274-9. doi: 10.2146/ajhp090251.

Abstract

PURPOSE

An adjustment factor (AF) was developed and evaluated to determine the best method for estimating aminoglycoside clearance (CL(amino)) and creatinine clearance (CL(cr)) in underweight patients.

METHODS

This study was a retrospective, multicenter, chart analysis of aminoglycoside pharmacokinetic data obtained between January 2000 and August 2006 at the University of Southern California University Hospital and Cedars-Sinai Medical Center. Adult patients were included in this study if they had received inpatient aminoglycoside therapy, were at least 60 inches tall, and were at least 10% below their ideal body weight (IBW). CL(cr) and CL(amino) were estimated and compared to actual CL(amino) using the Cockcroft-Gault equation with actual serum creatinine (SCr) (CG(SCr)), Cockcroft-Gault equation with SCr rounded to 1 mg/dL (CG(rnd)), and Cockcroft-Gault equation multiplied by an AF (CG(AF)). Results An AF of 0.69 was determined from 52 patients and tested in 53 separate patients. The CG(AF) method was more precise and less biased than the CG(SCr) equation; the CG(rnd) equation was less biased than the CG(SCr) equation; the CG(AF) method was more precise and less biased than the CG(rnd) equation, but this difference was not statistically significant. In underweight patients with an SCr concentration of > or = 1 mg/dL, the CG(AF) method had less bias compared with the CG(SCr) equation.

CONCLUSION

Both the CG(rnd) and CG(AF) methods of predicting CL(amino) in underweight patients were superior to the CG(SCr) equation. The CG(AF) method was more accurate in patients exhibiting greater differences between IBW and actual body weight.

摘要

目的

开发并评估调整因子(AF),以确定估算体重不足患者氨基糖苷类药物清除率(CL(amino))和肌酐清除率(CL(cr))的最佳方法。

方法

本研究为回顾性、多中心、图表分析,对 2000 年 1 月至 2006 年 8 月期间在南加州大学医院和雪松西奈医疗中心获得的氨基糖苷类药物药代动力学数据进行分析。纳入本研究的成年患者需满足以下条件:接受住院氨基糖苷类药物治疗、身高至少 60 英寸、实际体重比理想体重(IBW)低至少 10%。使用 Cockcroft-Gault 方程结合实际血清肌酐(SCr)(CG(SCr))、将 SCr 四舍五入至 1mg/dL 的 Cockcroft-Gault 方程(CG(rnd))和 Cockcroft-Gault 方程乘以 AF(CG(AF))估算 CL(cr)和 CL(amino),并将其与实际 CL(amino)进行比较。结果:从 52 例患者中确定了 0.69 的 AF,并在 53 例单独患者中进行了测试。CG(AF) 方法比 CG(SCr) 方程更精确且偏差更小;CG(rnd) 方程比 CG(SCr) 方程偏差更小;CG(AF) 方法比 CG(rnd) 方程更精确且偏差更小,但差异无统计学意义。在 SCr 浓度≥1mg/dL 的体重不足患者中,CG(AF) 方法与 CG(SCr) 方程相比偏差更小。

结论

在体重不足患者中,CG(rnd)和 CG(AF)预测 CL(amino)的方法均优于 CG(SCr)方程。CG(AF) 方法在 IBW 与实际体重差异较大的患者中更准确。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验